Combo Products Demand Unique Approval Process – FDA Think Tank
This article was originally published in The Pink Sheet Daily
Executive Summary
Collaboration between drug and device companies demands a hybrid FDA approval process, panelists agree at Oct. 11 “Think Tank” sponsored by FDA and the Duke Cardiovascular Research Institute.